MesenFlow Technologies R&D and Labs

MesenFlow Technologies has developed a platform to meet the demands of modern drug development. It is a bio-imaging technology designed to accelerate the drug development process & provide solutions to problems associated with species cross-reactivity, animal testing & understanding human disease. This has been achieved by using proprietary protocols on primary human cells, allowing the mechanism of action & translational relevance of a drug to be defined very early on in the development process. MesenFlow Technologies has recently extended this technology for use in cosmetics and nutrition. By using their technology, it is possible to explore the physiological impact of a cosmetic or nutraceutical candidate in the early development phase. Their services are particularly tailored to business environments where animal-free testing is mandatory, and an understanding of impact on human biology is paramount.
Headquarters: Geneva, Switzerland
Founded Date: 01.01.2016
Employees Number: 1—10
Estimated Revenue: <$1 Mn

Visit Website
https://twitter.com/mesenflow/
Register and Claim Ownership